MedPath

Study of combination chemotherapy of Albumin-bound paclitaxel / Cyclophosphamide in recurrent or metastatic breast cancer

Not Applicable
Recruiting
Conditions
Breast cancer
Registration Number
JPRN-UMIN000009616
Lead Sponsor
Yokohama City University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1allergy of the medication 2Serious complications 3Previous or current history of malignant neoplasm 4Clinically significant heart disease 5Peripheral neuropathy grade2 or greater 6Active infection 7Symptomatic brain metastasis 8Uncontrollable pleural effusion or ascites requiring 9During administraton of pentostatin 10With mental disorder which become problem on clinical practice 11Current pregnancy or lacation,or possibility of pregnancy 12Cases who physician judged improper to entry this trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determinate maximum tolerated dose and recommended dose
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath